Clinical Trials Browser

Phase 2 × Etanercept × Other hematologic neoplasm × Clear all

NCT00309907 2017-09-29

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

CNSGenitourinaryLymphoidOther hematologic neoplasmSarcoma

Blast Crisis, Burkitt Lymphoma, Wilms Tumor, Neuroblastoma, Recurrence, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT00509600 2012-08-07

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

Phase 2 Terminated

1 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Juvenile

NCT00217386 2010-09-15

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Phase 2 Completed

30 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00005853 2010-04-02

Biological Therapy in Treating Patients With Myelodysplastic Syndrome

Phase 2 Completed

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes